New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
10:00 EDTNMBL, JD, CCE, WMT, RKUS, NBS, MCD, VEEV, QTNT, MEG, DK, WM, SBUXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Coca-Cola Enterprises (CCE) initiated with a Neutral at ISI Group... Delek US (DK) initiated with a Buy at BofA/Merrill... JD.com (JD) initiated with a Buy at CLSA... McDonald's (MCD) initiated with a Strong Sell at Standpoint Research... Media General (MEG) initiated with a Buy at Benchmark Co.... NeoStem (NBS) initiated with a Speculative Buy at Benchmark Co.... Nimble Storage (NMBL) initiated with a Neutral at Macquarie... Quotient (QTNT) initiated with an Outperform at Cowen... Ruckus Wireless (RKUS) initiated with an Outperform at BMO Capital... Starbucks (SBUX) initiated with a Strong Sell at Standpoint Research... Veeva (VEEV) initiated with an Overweight at JPMorgan... Wal-Mart (WMT) initiated with a Strong Sell at Standpoint Research... Waste Management (WM) initiated with an Outperform at Imperial Capital.
News For CCE;DK;MCD;JD;MEG;NBS;NMBL;QTNT;RKUS;SBUX;VEEV;WMT;WM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
March 18, 2015
13:21 EDTSBUXStarbucks sees Q2 split adjusted EPS 32c-33c, consensus 65c
Subscribe for More Information
13:19 EDTSBUXStarbucks to begin trading on split adjusted basis on April 9
Comment from Starbucks Annual Meeting of Shareholders.
13:18 EDTSBUXStarbucks reports 2-for1 stock split
Subscribe for More Information
13:06 EDTSBUXStarbucks to open next Roastery location in Asia in 2016
Subscribe for More Information
13:05 EDTSBUXStarbucks to unveil two complementary delivery models
In an effort to integrate service solutions that meet the “on demand” customer, Starbucks will unveil two complementary delivery models including: A strategic collaboration with Postmates, a leading on-demand delivery service, which will allow customers to order their food and beverage items via the Starbucks mobile app and receive on-demand delivery within defined areas. This rapidly growing organization – operating in 22 markets with more than 1.5M deliveries to date – brings robust logistics technology, courier-enabled delivery and quality of service expertise. This Starbucks delivery pilot will begin in Seattle in the second half of 2015; A “Green Apron” barista delivery option enabling customers within specified office-buildings to order food and beverages for convenient delivery by Starbucks baristas. Supported by its world class real-estate capabilities, this model allows Starbucks to identify targeted solutions for environments that can benefit from an integrated service model. This Starbucks delivery test will begin in New York the second half of 2015.
13:04 EDTSBUXStarbucks reaffirms goal to grow market cap to $100B
Subscribe for More Information
12:58 EDTSBUXStarbucks to begin delivery services in NY, Seattle this year, WSJ reports
Subscribe for More Information
09:36 EDTWMTActive equity options trading on open
Subscribe for More Information
March 17, 2015
10:17 EDTJDFly Watch: Alibaba upgraded ahead of big lock-up expiration
A lock-up of Alibaba's (BABA) U.S. shares is set to expire tomorrow, enabling early investors the opportunity to sell 337M of the company's shares, or about 14% of its publicly traded stock, for the first time. This morning, research firm Stifel upgraded the stock to Buy, citing reduced regulatory risk and enhanced monetization trends. WHAT'S NEW: About 337M shares of Alibaba's stock will become available for sale tomorrow as a 180-day lock-up related to the company's IPO expires. Lock-up agreements, a typical feature of company stock offerings, prevent certain shareholders from selling for a set amount of time after the offering. Earlier today, Stifel analyst Scott Devitt upgraded Alibaba to Buy from Hold. After a Chinese regulator alleged that many of the products sold on Alibaba's marketplace were inauthentic, the headline risk facing the company has subsided because it has begun taking stronger measures to combat counterfeit products, according to Devitt. At current levels the stock reflects the regulatory risk the company is facing, the analyst added. Devitt believes that recent investments by Alibaba will accelerate the company's monetization trends and the experience of its customers over the longer term. He set a $99 price target on the shares. WHAT'S NOTABLE: Research firm William Blair upgraded the shares of another Chinese e-commerce company, JD.com (JD), to Outperform from Market Perform in a note to investors earlier today. As reasons for the upgrade, the firm cited increased confidence that the company can increase its market share further and its belief that the company's platform is becoming more appealing while its market reach is expanding. The Chinese government's increased scrutiny of Alibaba could also be boosting JD.com, the analyst stated. The firm noted that gross merchandise volume growth trends for JD.com accelerated throughout the quarters of 2014, which is in contrast to Alibaba. PRICE ACTION: In early trading, Alibaba rose 0.5% to $84.38, while JD.com gained 1% to $28.
10:00 EDTJDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:35 EDTJDJD.com upgraded to Outperform from Market Perform at William Blair
William Blair upgraded JD.com (JD) to Outperform citing an "attractive" valuation and its belief the company can gain market share in China's business-to-consumer e-commerce market. The firm notes gross merchandise volume growth trends for JD.com accelerated throughout the quarters of 2014, a contrast to competitor Alibaba (BABA). Shares of JD.com closed yesterday down 36c to $27.72.
07:07 EDTVEEVVeeva says selected by GlaxoSmithKline for multichannel CRM
Subscribe for More Information
07:06 EDTVEEVVeeva selected by GSK as global multichannel CRM partner
Subscribe for More Information
06:46 EDTMCDMcDonald's burn complaints to focus on corporate reponsibility, WSJ says
Subscribe for More Information
06:06 EDTMCDMcDonald's employees file complaints of burns, injuries, LA Times says
McDonald's employees have filed complaints against 28 McDonald's locations -- including nine owned by the corporation itself -- alleging they received burns on the job, reports the LA Times, citing statements by union-backed group Fast Food Forward. The complaints were lodged with the Occupational Safety and Health Administration and claim that greasy floors, lack of staff, and an extremely fast-paced environment elevate the risk of injury in McDonald's restaurants. Reference Link
March 16, 2015
11:08 EDTNMBLNimble Storage management to meet with Needham
Subscribe for More Information
07:16 EDTCCEConsumer Analyst Group of Europe to hold a conference
Subscribe for More Information
06:16 EDTWMTWal-Mart to sell Tide rival Persil in stores, WSJ reports
Subscribe for More Information
06:05 EDTNBSNeoStem announces PreSERVE AMI clinical trial one-year follow up results
NeoStem announced the presentation of updated efficacy and safety results from the one-year follow-up for its Phase 2 PreSERVE study and additional analyses of certain functional tests at ACC.15, the American College of Cardiology's 64th Annual Scientific Session and Expo, in San Diego, California. The one-year follow-up results are defined as all data accumulated until the last patient enrolled completed 12 month follow-up. Thus, the results actually represent data from patients with a median follow-up of 18 months. The PreSERVE study is NeoStem's clinical trial evaluating NBS10 which is being developed to treat damaged heart muscle following an acute myocardial infarction. One-year follow-up safety data collected thus far supports the trial's 6 month results presented at the American Heart Association's Scientific Sessions in November 2014. The ACC presentation contained updated safety and exploratory efficacy data and additional analyses conducted on left ventricular ejection fraction, or LVEF, data. Clinical Endpoint Committee adjudication of major adverse cardiac events, or MACE, was performed on the 6 month data reported previously and was not performed for new events. The next prescribed adjudication of MACE is currently planned at the end of patient follow-up. At 12-month follow-up, no meaningful safety or tolerance differences were observed between treatment and control groups. In this updated analysis, no additional deaths were reported in the treatment or control groups beyond those previously reported in the six month analysis. In addition, in post hoc subset analyses based on the number of cells patients received, serious adverse event frequency continues to show numerical improvement at all cell doses when compared to control.
05:42 EDTCCECoca-Cola Enterprises affirms FY15 EPS view of up 6%-8%
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use